How many employees does Regeneron Pharmaceuticals, Inc. have?

Regeneron Pharmaceuticals, Inc. reported 15,410 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 4, 2026. That is up 2.0% from a year earlier.

What is Regeneron Pharmaceuticals, Inc.'s revenue per employee?

Regeneron Pharmaceuticals, Inc. brought in $14.3B of revenue in fiscal Dec 2025, which is $931K per employee. That ranks 15 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Regeneron Pharmaceuticals, Inc. employees and revenue per employee

REGN · Biotechnology · $75.7B market cap

Regeneron Pharmaceuticals, Inc. had 15,410 employees at the end of fiscal Dec 2025, up 2.0% from a year earlier. Revenue for the year was $14.3B, up 1.0% from a year earlier, or $931K per employee. Headcount grew faster than revenue.

Employees

15,410

+2.0% YoY

Revenue

$14.3B

+1.0% YoY

Revenue / employee

$931K

Peer median $602K

Rank in industry

15 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

REGN employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	15,410	$14.3B	$931K	+2.0%	+1.0%
Dec 2024	15,106	$14.2B	$940K	+12.3%	+8.3%
Dec 2023	13,450	$13.1B	$975K	+13.5%	+7.8%
Dec 2022	11,851	$12.2B	$1.03M	+14.3%	-24.3%
Dec 2021	10,368	$16.1B	$1.55M	+13.6%	+89.1%
Dec 2020	9,123	$8.50B	$931K	+12.6%	+29.6%
Dec 2019	8,100	$6.56B	$810K	+9.5%	-2.3%
Dec 2018	7,400	$6.71B	$907K	+19.4%	+14.3%
Dec 2017	6,200	$5.87B	$947K	+14.8%	+20.8%
Dec 2016	5,400	$4.86B	$900K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Regeneron Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
UTHR United Therapeutics Corporation	1,400	$3.18B	$2.27M	Efficient growth
EXEL Exelixis, Inc.	1,077	$2.32B	$2.15M	Leaner
VRTX Vertex Pharmaceuticals Incorporated	6,400	$12.1B	$1.89M	Efficient growth
INCY Incyte Corporation	2,844	$5.14B	$1.81M	Efficient growth
ALNY Alnylam Pharmaceuticals, Inc.	2,500	$3.71B	$1.49M	Efficient growth
NBIX Neurocrine Biosciences, Inc.	2,000	$2.86B	$1.43M	Efficient growth
BMRN BioMarin Pharmaceutical Inc.	3,221	$3.22B	$1.00M	Efficient growth
REGN Regeneron Pharmaceuticals, Inc.	15,410	$14.3B	$931K	Hiring ahead
FTRE Fortrea Holdings Inc.	14,300	$2.72B	$190K	Leaner

Every Healthcare company

Questions about Regeneron Pharmaceuticals, Inc.

How many employees does Regeneron Pharmaceuticals, Inc. have?: Regeneron Pharmaceuticals, Inc. reported 15,410 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 4, 2026. That is up 2.0% from a year earlier.
What is Regeneron Pharmaceuticals, Inc.'s revenue per employee?: Regeneron Pharmaceuticals, Inc. brought in $14.3B of revenue in fiscal Dec 2025, which is $931K per employee. That ranks 15 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare REGN with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Regeneron Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 4, 2026. This is data, not a recommendation to buy or sell REGN.